SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027036
Filing Date
2022-11-14
Accepted
2022-11-14 07:29:10
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20220930_10q.htm   iXBRL 10-Q 1067722
2 EXHIBIT 10.1 ex_446032.htm EX-10.1 468480
3 EXHIBIT 31.1 ex_415911.htm EX-31.1 15825
4 EXHIBIT 31.2 ex_415912.htm EX-31.2 15402
5 EXHIBIT 32.1 ex_415913.htm EX-32.1 8607
  Complete submission text file 0001437749-22-027036.txt   4952089

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20220930.xsd EX-101.SCH 40105
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20220930_cal.xml EX-101.CAL 28401
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20220930_def.xml EX-101.DEF 278611
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20220930_lab.xml EX-101.LAB 254661
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20220930_pre.xml EX-101.PRE 294315
45 EXTRACTED XBRL INSTANCE DOCUMENT wint20220930_10q_htm.xml XML 559914
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 221380239
SIC: 2836 Biological Products, (No Diagnostic Substances)